COMBINATION THERAPY WITH CONTROLLED-RELEASE CNP AGONISTS

Abstract

The present invention relates to a combination of a CNP agonist and at least one further biologically active moiety or drug for use in a method for the treatment or prevention of disorders that benefit from growth stimulation, pharmaceutical compositions comprising at least one CNP agonist, preferably a controlled-release CNP agonist, wherein the pharmaceutical composition comprises at least one further biologically active moiety or drug, to the use of these pharmaceutical compositions as medicaments, to their use in the treatment of disorders that benefit from growth stimulation and to methods of preventing or treating a patient having a disorder that benefits from growth stimulation.